In summary, RCC1 knockdown exacerbates chemotherapy-induced DNA damage by impairing the expression and nuclear localization of DNA repair proteins, thereby sensitizing both CRC and drug-resistant CRC cells to 5-FU and Doxo. Here, RCC1 is linked to colorectal carcinoma.